Target intelligence / Profile preview

Antibody fragment crystallizable region (Fc region)

Target
Fc region
Molecular classification
Other (immunoglobulin constant region)
01

Overview

The Fc region is the tail portion of an immunoglobulin (antibody) molecule required for recruiting effector functions of the immune system. When an antibody is bound to a target cell (e.g., via its Fab region), the Fc region remains exposed and can interact with Fc receptors (FcRs) on immune cells such as macrophages, natural killer cells, and dendritic cells, as well as proteins of the complement system. These interactions trigger processes such as phagocytosis, ADCC, and complement-mediated lysis, crucial for the destruction of antibody-coated pathogens or tumor cells. The structure and glycosylation patterns of the Fc region influence its binding to different Fc receptors and thereby modulate the intensity and type of immune response. Many therapeutic antibodies are engineered to optimize Fc region interactions for enhanced efficacy or reduced toxicity.

Other names
Fragment crystallizable regionFc fragmentFc domain
02

Mechanism of action

Fc receptor engagement leading to ADCC and phagocytosis Complement activation (antibody-dependent complement deposition) Modulation of immune cell activity (via Fcγ, Fcε, Fcα receptors)

03

Biological functions

Immune responseOpsonizationCell lysisDegranulationAntibody-dependent cellular cytotoxicity (ADCC)Complement activation
04

Disease associations

CancerInfectionInflammationAutoimmune diseases
05

Safety considerations

Excessive immune activation (cytokine release syndrome)Cellular depletion (off-target cytotoxicity)Autoimmunity (antibody-mediated cell damage)Hypersensitivity/anaphylaxis
06

Interacting drugs

Monoclonal antibodies (therapeutics and biosimilars)

3 more in the full profile.

07

Biomarkers

Fc glycosylation state (affecting effector function)FcγR polymorphisms (predicting patient response)

Beyond the preview

Go deeper on Antibody fragment crystallizable region (Fc region).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibody fragment crystallizable region (Fc region).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call